Trusted by 100,000+ International Patients
HIPEC: Thailand vs Turkey
Cost, Quality & Recovery Compared
$35000
Thailand Starting Cost
$28500
Turkey Starting Cost
See how these top medical tourism destinations compare for HIPEC.
| Comparison Factor | Thailand | Turkey | Winner |
|---|---|---|---|
| Average Cost (in USD) | 35000 - 45000 | 28500 - 40000 | Turkey |
| Success Rate (Min and Max) | 55% – 80% | 52% – 78% | Thailand |
| Advanced Technology | Advanced oncology centres perform CRS + HIPEC using specialised perfusion systems, high-resolution PET-CT imaging, modern operating theatres, and dedicated oncology ICUs. | Tertiary surgical oncology hospitals with CRS+HIPEC capability and structured ICU pathways in major centres. | Both Equal |
| JCI Accredited Hospitals | 25+ | 25+ | Both Equal |
| Visa Process | Medical Visa (3–10 working days; extendable) | Medical Visa / e-Visa (5-10 days depending on nationality) | Both Equal |
*Costs are estimates and may vary based on hospital, complexity, and package inclusions. See detailed cost breakdown below
Understand exactly where your money goes. Both countries offer all-inclusive packages, but here's how the costs typically break down.
Best for Budget-Conscious Patients
Offered Package Price (Additional Cost Excluded)
Top Hospitals: Bangkok Hospital
Best for Flexible Donor Requirements
Offered Package Price (Additional Cost Excluded)
Top Hospitals: Liv Hospital Ulus , Medicana Camlica Hospital , Medicana Bahcelievler Hospital , Acibadem Hospital Taksim
Want a personalized cost estimate based on your specific condition?
Get Your Free QuoteBoth Thailand and Turkey maintain world-class healthcare standards with internationally accredited hospitals and highly trained medical professionals.
Many leading hospitals in Thailand hold JCI accreditation and operate advanced oncology and surgical oncology departments.
Clinical outcomes depend on tumour burden (PCI score), surgical completeness (CC score), and ICU-level postoperative care in specialised centres.
Cancer treatments and chemotherapy protocols follow Thailand’s Ministry of Public Health regulations and international oncology safety standards.
25+ JCI-accredited hospitals and internationally recognised tertiary oncology centres.
Comparable tertiary centres follow European-aligned surgical oncology protocols for CRS+HIPEC.
Regulated under the Turkish Ministry of Health, oncology centres operate under national governance and drug safety standards.
| Quality Metric | Thailand | Turkey |
|---|---|---|
Accredited Hospitals | 25+ | 25+ |
CRS + HIPEC Availability | Yes | Yes |
ICU Support Level | Advanced (tertiary) | Advanced (tertiary) |
Top Speciality Hospital Hubs | Bangkok, Phuket, Chiang Mai | Istanbul, Ankara |
Both countries have highly qualified and experienced medical specialists trained at premier institutions worldwide. Here's what sets them apart.
Cancer Specialist
Procedure volumes concentrated in specialised oncology centres
Cancer Specialist
Concentrated in tertiary oncology hospitals; experience varies by centre.
All surgeons listed on Medigence are verified for their medical license, board certifications, hospital affiliations, and patient outcomes. We conduct background checks and regularly update our database to ensure you're connected with the best medical professionals.
Beyond medical excellence, your comfort during treatment matters. Compare the patient experience at top hospitals in both destinations.
World-class hospitals, exceptional value
Leading cancer hospitals in Thailand provide advanced operating rooms equipped with HIPEC perfusion machines for heated chemotherapy circulation, specialised surgical oncology ICUs, advanced imaging facilities, and integrated cancer care, including pathology, oncology pharmacy, and rehabilitation services.
Luxury healthcare experience
Major oncology hospitals in Turkey are equipped with modern operating theatres, HIPEC perfusion technology for heated intraperitoneal chemotherapy, dedicated surgical oncology ICUs, advanced imaging (PET-CT, MRI), and integrated pathology and oncology pharmacy services. These facilities support comprehensive multidisciplinary cancer treatment.
Plan your medical journey with confidence. Here's everything you need to know about travel, visas, and accommodation in both countries.
We provide end-to-end travel assistance including visa facilitation, airport pickups, hotel bookings near your hospital, and local support throughout your stay. Our patient coordinators handle all logistics so you can focus on recovery.
Understanding the recovery process helps you plan better. Here's what to expect after HIPEC in both countries.
HIPEC is performed during cytoreductive surgery where heated chemotherapy is circulated inside the abdominal cavity to target residual cancer cells.
Patients require ICU monitoring immediately after surgery due to the complexity of the procedure.
A short local stay after discharge is recommended for wound care and early recovery monitoring.
Gradual recovery occurs with nutritional support, physiotherapy, and regular oncology follow-ups.
In-person follow-ups recommended at 3, 6, 12 months. Telemedicine available.
HIPEC is performed during cytoreductive surgery (CRS), where heated chemotherapy is circulated inside the abdominal cavity after tumour removal.
Patients usually require ICU monitoring immediately after surgery.
A short local stay after discharge is recommended for wound care, nutritional support, and recovery monitoring.
Recovery progresses gradually with dietary management, physiotherapy, and oncology follow-up visits.
Comprehensive telemedicine follow-up program. Return visits at 6, 12 months if possible.
HIPEC recipients require lifelong immunosuppressant medications. Ensure you have a plan for obtaining these medications and regular blood monitoring in your home country before traveling abroad for surgery.
Every medical procedure carries risks. We believe in complete transparency so you can make a fully informed decision about your HIPEC journey.
Higher-than-average surgical risk due to extensive cytoreduction; ICU and infection pathways are critical.
Expected due to major abdominal surgery; managed with protocols.
Possible due to nutritional depletion; requires nutrition optimisation.
Risk of bowel complications, anastomotic leak, and sepsis; it depends on the extent of surgery.
Chemo agent exposure can affect the kidneys and marrow; supportive monitoring is required.
The right choice depends on your specific situation. Here's a clear guide to help you decide which destination aligns with your needs.
Patients diagnosed with peritoneal surface malignancies such as colorectal cancer with peritoneal spread, ovarian cancer, appendix cancer, or pseudomyxoma peritonei who may benefit from cytoreductive surgery combined with heated intraperitoneal chemotherapy (HIPEC).
Patients diagnosed with peritoneal surface malignancies, including colorectal cancer metastasis to the peritoneum, ovarian cancer, appendiceal cancer, or pseudomyxoma peritonei, who may benefit from cytoreductive surgery combined with heated intraperitoneal chemotherapy (HIPEC).
Our medical tourism experts can analyze your case and recommend the best destination based on your medical history and budget.
Follow this step-by-step framework to make the right choice for your HIPEC journey.
Doctors confirm diagnosis and evaluate peritoneal disease using the PCI score.
Surgeons assess the feasibility of complete cytoreduction before HIPEC.
Plan ICU recovery, hospital stay, and post-operative care.
Budget for surgery, ICU stay, medicines, and possible complications.
Schedule follow-up monitoring and additional therapy if required.
Let our medical tourism experts guide you through the process. We'll help you:
No obligation • Free consultation • Response within 24 hours
Surgical Oncologist
15 Years of Experience
Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More
